Cortical Neurons In Frontotemporal Dementia is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Frontotemporal dementia (FTD) is a heterogeneous group of neurodegenerative disorders characterized by progressive atrophy of the frontal and temporal lobes. Cortical neurons in these regions are particularly vulnerable to degeneration in FTD, leading to the characteristic changes in personality, behavior, and language.
- NFT Formation: Neurofibrillary tangles composed of hyperphosphorylated tau protein accumulate in cortical neurons
- 3R/4R Tau: Both 3-repeat and 4-repeat tau isoforms are involved, depending on the FTD subtype
- Pick Bodies: Spherical tau aggregates characteristic of Pick's disease, a subtype of FTD
- TDP-43 Inclusions: Type A, B, and C TDP-43 pathology in approximately 95% of FTD cases
- Nuclear Clearance: Loss of TDP-43 from the nucleus to cytoplasmic inclusions
- RNA Dysregulation: Impaired RNA processing due to TDP-43 sequestration
- Prefrontal Cortex: Executive function and decision-making affected early
- Motor Cortex: Primitive reflex release and motor planning deficits
- Orbitofrontal Cortex: Disinhibition and social conduct problems
- Anterior Temporal Lobe: Semantic memory loss and language dysfunction
- Superior Temporal Gyrus: Auditory processing and speech comprehension
- Inferior Temporal Cortex: Object recognition deficits
- Large projection neurons particularly vulnerable
- Early tau accumulation in apical dendrites
- Disruption of long-range cortical connections
- Parvalbumin and somatostatin-positive neurons affected
- Contributes to network hyperexcitability
- Loss of inhibitory control
- Kinases: GSK3β, CDK5, DYRK1A upregulated
- Phosphatases: PP1, PP2A activity reduced
- Sequestration of normal tau and microtubule dysfunction
- Reduced ATP production in affected neurons
- Increased reactive oxygen species
- Impaired calcium homeostasis
- Microglial activation surrounding affected neurons
- Cytokine release: IL-1β, TNF-α, IL-6
- Complement system involvement
- Disinhibition and socially inappropriate behavior
- Apathy and loss of initiative
- Compulsive behaviors and dietary changes
- Non-fluent/agrammatic variant: Broca's area involvement
- Semantic variant: Anterior temporal lobe atrophy
- Logopenic variant: Left posterior temporal/inferior parietal
- Tau aggregation inhibitors in clinical trials
- Antisense oligonucleotides targeting tau
- Neuroprotective agents under investigation
- Gene therapy approaches
- Stem cell transplantation
- Immunotherapy targeting pathological proteins
The study of Cortical Neurons In Frontotemporal Dementia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Rascovsky K, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456-2477. PMID:21810890
- Seelaar H, et al. Clinical, pathological and genetic heterogeneity of frontotemporal dementia. Brain. 2011;134(Pt 9):2445-2461. PMID:21810889
- Neumann M, et al. TDP-43 pathology in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. J Mol Neurosci. 2011;45(3):522-531. PMID:21882102
- Goedert M, et al. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Cold Spring Harb Perspect Med. 2017;7(9):a024240. PMID:28242767
- Boxer AL, et al. Frontotemporal dementia: update on emerging diagnostic and therapeutic strategies. J Geriatr Psychiatry Neurol. 2013;26(2):69-79. PMID:23508251
- Rohrer JD, et al. The clinical and neuroanatomical profile of frontotemporal dementia linked to chromosome 3. Brain. 2011;134(Pt 9):2568-2581. PMID:21865558
- Snowden JS, et al. Cognitive phenotypes in progressive aphasia. Brain. 2011;134(Pt 9):2544-2556. PMID:21865061
- Tsai RM, Boxer AL. Therapy and clinical trials in frontotemporal dementia: past, present, and future. J Neurochem. 2016;139 Suppl 1:215-231. PMID:26709871